CHRNA7 and Anxiety: Accumulating evidence from preclinical studies suggests that activation of α7-nAChR signalling results in suppression or prevention of anxiety.20–22 The present study is the first to show an anxiolytic effect of an α7-nAChR agonist in a placebo-controlled clinical trial.